ClinConnect ClinConnect Logo
Search / Trial NCT06758102

Dance Study for Post-surgical Pain in Breast Cancer Survivors

Launched by DANA-FARBER CANCER INSTITUTE · Dec 26, 2024

Trial Information

Current as of November 14, 2025

Not yet recruiting

Keywords

Breast Cancer Survivorship Breast Cancer Survivor Survivorship Pain, Postoperative Ppsp Persistent Post Surgical Pain

ClinConnect Summary

The Dance Study is a clinical trial designed to explore how a 12-week virtual dance program can help improve pain and quality of life for women who have experienced persistent post-surgical pain after breast cancer surgery, such as a mastectomy or lumpectomy. The study aims to see if this enjoyable and gentle form of exercise can make a difference for those living with ongoing pain following their treatment.

To participate in this study, women aged 18 and older who have a history of early-stage invasive breast cancer may be eligible if they have been experiencing moderate to severe pain for at least three months after surgery. Participants will need to be able to read and understand English and perform seated exercises. This study is not yet recruiting, but it offers a unique opportunity for those struggling with pain to potentially find relief through movement and dance. If you or someone you know is interested, it’s a great chance to engage in a supportive program while contributing to important research.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • History of Stage 0-III invasive breast cancer
  • Having undergone lumpectomy or mastectomy
  • Moderate to severe persistent post-surgical pain, as defined by pain scores ≥3 on a numerical rating scale (NRS) of 0-10 (10 being the most severe pain) at least 3 months after completion of surgery, chemotherapy, and/or radiation
  • Pain scores of 3-4 are categorized as moderate pain; scores of 5-10 are categorized as severe pain26
  • Age ≥ 18 years
  • Able to read and understand English (to complete required questionnaires and participate in classes)
  • Ability to provide informed consent
  • Ability to perform seated exercises
  • Exclusion Criteria:
  • Unstable cardiovascular disease in the last 6 months
  • Psychiatric disorders or conditions that would preclude participation in the study intervention (e.g. untreated major depression or psychosis, untreated substance use disorder, severe personality disorder)
  • Metastatic breast or other concurrent cancer
  • Pregnant
  • Recent history of attending regular dance or similar classes (e.g. yoga or tai chi classes i.e. 20 or more classes in the past 6 months)
  • Planned surgery anticipated during the intervention period
  • History of a chronic medical condition that has the potential to significantly impact upper extremity function (e.g. stroke, Parkinson's disease, Multiple Sclerosis)
  • Currently enrolled in a physical therapy course
  • Presence of medical conditions or medications that would prohibit participation in an exercise program

About Dana Farber Cancer Institute

The Dana-Farber Cancer Institute is a premier cancer research and treatment institution located in Boston, Massachusetts. Renowned for its commitment to advancing cancer care through innovative research, the institute integrates cutting-edge clinical trials with a multidisciplinary approach to patient care. With a focus on translating scientific discoveries into effective therapies, Dana-Farber collaborates with a network of leading researchers and healthcare professionals to improve outcomes for patients with cancer. The institute’s dedication to education, advocacy, and community engagement further underscores its mission to eradicate cancer and enhance the quality of life for those affected by the disease.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Jennifer Ligibel, MD

Principal Investigator

Dana-Farber Cancer Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported